Resulting Issuer. In accordance with the approval of the Schyan Shareholders of the Resulting Issuer Director Matters at the Schyan Meeting, Schyan will, upon completion of the Business Combination, be known as Trulieve Cannabis Corp. (the “Resulting Issuer”), and its articles will provide that it will have a minimum of one (1) director and a maximum of ten (10) directors and the following will be the directors (the “Resulting Issuer Directors”) and officers (the “Resulting Issuer Officers”) of the Resulting Issuer immediately following the completion of the Merger: Directors Xxx Xxxxxx (Chairman) Xxxxxxxx Xxxxxx Xxxx Xxxxxxxx Xxxxxx Xxxxxxx Xxxxxxx Xxx Xxxxxxx X. X’Xxxxxxx Xx. Officers Name Title Xxx Xxxxxx Chief Executive Officer Xxxxx Xxxxxxxxxx Chief Financial Officer Xxxxx Xxxxxxx Investor Relations Xxxxx Xxxxxxx Chief Information Officer Xxxxx Xxxxxxxx Research and Development Manager
Resulting Issuer. (a) Name. The name of the Resulting Issuer shall be “Love Pharmaceuticals Inc.”.
Resulting Issuer. Subject to the approval of the holders of BC Co Common Shares, BC Co, upon completion of the Merger is to be known as “Breathtec Biomedical, Inc.” (the “Resulting Issuer”), shall initially have a minimum of three (3) and a maximum of five (5) directors and the following shall be the directors and officers of the Resulting Issuer: Directors Xxx Xxxxx; Xxx Xxxxxxxxxx; Xxxxxxx Xxxxxx; and Xxxx Xxxxxxxx Officers Name Title Xxxx Xxxxxxxxx Chief Executive Officer Xxxxxxx Xxxxxx Chief Financial Officer Xxx Xxxxxxxxxx Chief Technology Officer Xxx Xxxxx President and Secretary
Resulting Issuer. Subject to the approval of holders of Apogee Common Shares, Apogee will, upon completion of the Merger, change its name to “Halo Labs Inc.” (the “Resulting Issuer”), and have a minimum of seven (7) directors and the following will be the directors and officers of the Resulting Issuer immediately following the completion of the Merger:
Resulting Issuer. Digital will, upon completion of the Business Combination, be known as Planet Based Foods Global Inc. (the “Resulting Issuer”), and the following will be the directors (the “Resulting Issuer Directors”) and officers (the “Resulting Issuer Officers”) of the Resulting Issuer immediately following the completion of the Merger: Directors Xxxxxxx Xxxxx, Xxxxxxxx Xxxx Xxxxxxxxx, Xxxxx Xxxxxx, Xxxxx Xxxxxx and Xxx Xxxxxxx Officers Name Title Xxxxxxx Xxxxx President/CEO Xxxxxxxx Xxxx Xxxxxxxxx COO Xxxxxx Xxxxx Chief Innovation Officer Xxxxx Xxxxx CFO
Resulting Issuer. FogChain will, upon completion of the Merger, change its name to “Avisa Diagnostics Inc.” (the “Resulting Issuer”), and the following will be the directors and officers of the Resulting Issuer immediately following the completion of the Merger: Directors Xx. Xxxxx X. Joseph Xx. Xxxxx Xxxx Mr. Xxxxxxx Xxxxxx Officers Name Title Xx. Xxxxx X. Joseph Chairman, President and Chief Executive Officer Xx. Xxxxxxx Xxxxxx Vice President, Chief Financial Officer and Corporate Secretary
Resulting Issuer. (a) Name Change. Immediately following the completion of the Amalgamation, CHCI will effect the Name Change.
Resulting Issuer. Subject to the approval of the holders of BC Co Common Shares, BC Co, upon completion of the Merger is to be known as “H-Source International Ltd.” (the “Resulting Issuer”), shall initially have a minimum of three (3) and a maximum of five (5) directors and the following shall be the directors and officers of the Resulting Issuer: Directors Xxxx X. Xxxxxx Xxxxxx Xxxxxx Xxxxxx X. Xxxxxxxxxx, Xx. Officers Name Title Xxxx X. Xxxxxx Chief Executive Officer Xxxxxx Xxxxxx Xxxxxx Xxx President Chief Financial Officer
Resulting Issuer. 15 2.4 Effect of Certificate of Amalgamation ........................................................................... 16 2.5 Manner of Conversion of Issued Securities ................................................................... 17 2.6 Certificates ..................................................................................................................... 18 2.7
Resulting Issuer. The Parties agree that upon completion of the Transaction, Blackstone will be the resulting issuer, carry on the business of Lattice, and have the capital structure set out in Schedule “C-1” and organizational structure set out in Schedule “C-2” of this Agreement (the “Resulting Issuer”).
